NeuroToxicology Announcements

A Virtual Special Issue of NeuroToxicology Peer-Reviewed Articles from the Proceedings of INA-18

  • Manuscripts describing scientific presentations from the INA-18 conference will be considered for inclusion in the peer-reviewed proceedings to be published in a virtual special issue of NeuroToxicology
  • Manuscripts may be original research, a critical review article, a short communication, or a commentary
  • Submission of a manuscript is not a guarantee of acceptance for publication in the journal. All manuscripts will go through the regular peer-review process of NeuroToxicology
  • Submission deadline for the INA-18 special issue is December 1, 2023
  • Questions? See Pam Lein, Ed Levin, Tim Shafer or Remco Westerink

Call for High Quality Images in Neurotoxicology for NeuroToxicology Covers

The Editors-in-Chief of the journal NeuroToxicology are soliciting high-quality images from your research in neurotoxicology to feature as the cover image on the journal’s bimonthly issues. The Elsevier Senior Publisher for Elsevier’s Toxicology portfolio, Jagna Mirska-Gent, has agreed to provide open promotional access for one article accepted for publication in NeuroToxicology to individuals whose image is chosen to be featured as a cover image. Open promotional access (which means the article is freely available without paying OpenAccess fees, but unlike OpenAccess the publisher retains the copyright) can be used for an article unrelated to the image chosen for the cover image and images submitted for consideration do not need to be associated with an article submitted to the journal.

Please submit high quality images along with a brief description of the image (including identification of the individual(s) who generated the image) to the Editors-in-Chief, Pamela Lein (pjlein@ucdavis.edu) and Dr. Remco Westerink (r.westerink@uu.nl) along with assurance that there are no copyright issues associated with NeuroToxicology using the image. If you have any questions, please contact either Dr. Lein or Dr. Westerink.